Publications by authors named "Anri Inaki"

: Alpha radionuclide therapy has emerged as a promising novel strategy for cancer treatment; however, the therapeutic potential of Ac-labeled peptides in pancreatic cancer remains uninvestigated. : In the cytotoxicity study, tumor cells were incubated with Ac-DOTA-RGD. DNA damage responses (γH2AX and 53BP1) were detected using flowcytometry or immunohistochemistry analysis.

View Article and Find Full Text PDF

Objective: To investigate the clinical utility of a new anthropomorphic phantom that reproduces the chest and abdomen better than the conventional National Electrical Manufacturers Association (NEMA) body phantom, count rates and image quality of PET images obtained from patients were evaluated.

Methods: Anthropomorphic phantoms were used to include radioactivity in the lung, liver, kidney, and background regions. Two NEMA body phantoms were used for chest and abdominal assessments.

View Article and Find Full Text PDF

Background: Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceuticals allow whole-body imaging to detect prostate cancer (PC). Positron emission tomography imaging using gallium-68 (Ga)-PSMA-11 has been shown to have a favorable safety and tolerability profile and high diagnostic performance. The study evaluates the safety and pharmacokinetics of Ga-PSMA-11 in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer.

View Article and Find Full Text PDF

Noise equivalent count density (NEC density ) is often used to evaluate the image quality of whole-body fluorodeoxyglucose tomography tests. However, this index is calculated using the patient volume, which is difficult to obtain at every facility. In this study, we proposed new image quality indices that can be evaluated at all facilities.

View Article and Find Full Text PDF

A 59-year-old woman with metastatic pancreatic insulinoma, having undergone several treatment regimens including sunitinib, everolimus, lanreotide and streptozocin plus 5-fluorouracil, was admitted to our hospital because of frequent hypoglycemic attacks. These were refractory to medical treatment using diazoxide and required frequent daily intravenous glucose infusions. She was started on capecitabine and temozolomide (CAPTEM), followed by initiation of Lu-DOTATATE peptide receptor radionuclide therapy (PRRT).

View Article and Find Full Text PDF

Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy (RIT) in a University Hospital setting. This retrospective study included 62 patients with lung metastases from DTC who received RIT between March 2005 and December 2016.

View Article and Find Full Text PDF

Objective: [Lu]Lu-PSMA-617 is a radioisotope used in nuclear medicine. It is necessary to take appropriate measures to limit its exposure and ensures its airborne concentrations do not exceed legally permitted levels. Therefore, the purpose of this study was to measure the airborne radioactivity concentration in the inpatient room after administering [Lu]Lu-PSMA-617 to humans.

View Article and Find Full Text PDF

Therapeutic nuclear medicine is an approach to treating malignant tumors by irradiating the target tissue from within. It shows comprehensive efficacy for all lesions including metastatic foci, and it is generally less toxic than chemotherapy. It is already widely utilized in the United States and Europe, where advanced research has yielded abundant evidence on novel radioisotope drugs for cancers, such as thyroid cancer, prostate cancer, breast cancer, and renal cancer.

View Article and Find Full Text PDF

Background: We aimed to explore how the severity of myocardial ischemia affects myocardial sigma-1 receptor (Sig-1R) expression using I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (I-OI5V) imaging.

Methods And Results: The left coronary artery was occluded for 30, 20, and 10 minute, to vary the severity of myocardial ischemia, followed by reperfusion. Dual-tracer autoradiography of the left ventricular short-axis slices was performed 3 and 7 days after reperfusion.

View Article and Find Full Text PDF

Objectives: I-ioflupane has been clinically applied to dopamine transporter imaging and visual interpretation assisted by region-of-interest (ROI)-based parameters. We aimed to build a multivariable model incorporating machine learning (ML) that could accurately differentiate abnormal profiles on I-ioflupane images and diagnose Parkinson syndrome or disease and dementia with Lewy bodies (PS/PD/DLB).

Methods: We assessed I-ioflupane images from 239 patients with suspected neurodegenerative diseases or dementia and classified them as having PS/PD/DLB or non-PS/PD/DLB.

View Article and Find Full Text PDF

Aim: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours of chromaffin cells. Several modalities are currently available to treat patients with PPGL. These treatment modalities include surgery, chemotherapy, molecular targeted therapy and radiopharmaceuticals.

View Article and Find Full Text PDF

The use of effective shielding materials against radiation is important among medical staff in nuclear medicine. Hence, the current study investigated the shielding effects of a commercially available tungsten apron using gamma ray measuring instruments. Further, the occupational radiation exposure of nurses during I-meta-iodo-benzyl-guanidine (I-MIBG) therapy for children with high-risk neuroblastoma was evaluated.

View Article and Find Full Text PDF

Background: Volumetric evaluation of Technetium-pyrophosphate (Tc-PYP) SPECT/CT is a useful method for assessing transthyretin cardiac amyloidosis (ATTR-CA). We investigated the methodology and assessed its relationship with conventional parameters.

Methods And Results: We retrospectively evaluated Tc-PYP SPECT/CT scans of 25 patients who underwent endomyocardial biopsy and/or gene testing.

View Article and Find Full Text PDF

Objective: In this phase II study, we aimed to investigate the efficacy and safety of single-dose [I]meta-iodobenzylguanidine (I-mIBG) therapy in patients with refractory pheochromocytoma and paraganglioma (PPGL).

Patients And Methods: This study was designed as an open-label, single-arm, multi-center, phase II clinical trial. The enrolled patients were administered 7.

View Article and Find Full Text PDF

Purpose: Paediatric high-risk neuroblastoma has poor prognosis despite modern multimodality therapy. This phase I/II study aimed to determine the safety, dose-limiting toxicity (DLT), and efficacy of high-dose I-meta-iodobenzylguanidine (I-mIBG) therapy combined with single high-dose chemotherapy (HDC) and haematopoietic stem cell transplantation (HSCT) in high-risk neuroblastoma in Japan.

Methods: Patients received 666 MBq/kg of I-mIBG and single HDC and HSCT from autologous or allogeneic stem cell sources.

View Article and Find Full Text PDF

Objective: Angiogenesis is an important process facilitating the healing process after myocardial infarction. I-RGD imaging may be a promising candidate to image angiogenesis but may also detect inflammation.

Methods: Left coronary artery was occluded for 30 min, followed by reperfusion in a rat model (n = 31).

View Article and Find Full Text PDF

Objective: Given the rarity of refractory pheochromocytoma and paraganglioma (PPGL), outcomes and prognostic factors after I-metaiodobenzylguanidine (I-mIBG) treatment still remain unclear. Therefore, this study evaluated whether baseline characteristics at initial I-mIBG therapy and imaging response to repeated I-mIBG therapy could be prognostic factors for refractory PPGL.

Methods: All patients [n = 59 (male/female = 35/24), median age; 49.

View Article and Find Full Text PDF

I-3-iodobenzylguanidine or I-iobenguane (3-(I) iodobenzylguanidine or I-iobenguane [I-MIBG]) is a radioactive agent that is specifically accumulated in tumor cells such as pheochromocytoma and neuroblastoma. Due to its cytotoxic beta ray emitted from I, it has been developed as an agent for radioisotope therapy and some researchers have reported its effectiveness. In this study, based on the patients' data from previous clinical trials of I-MIBG therapy, we evaluated the radiation safety for public exposure caused by radiation emitted from patients who received I-MIBG.

View Article and Find Full Text PDF

Background: This study chronologically evaluated the expression of the intensity and distribution of the sigma-1 receptor (σ1R) demonstrated by radiolabeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) in a rat model of myocardial ischemia and reperfusion.

Methods and results: The left coronary artery was occluded for 30 min, followed by reperfusion. Dual-tracer autoradiography with I-OI5V and Tc-MIBI was performed to assess the spatiotemporal changes in I-OI5V uptake (n=5-6).

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the use of positron emission tomography-computed tomography (PET-CT) to evaluate skeletal muscle metabolism during pitching, as traditional electromyography (EMG) is limited for deep muscle assessment.
  • Ten skilled pitchers threw baseballs at maximum effort before and after receiving a glucose tracer, with PET-CT images taken afterward to measure muscle glucose uptake.
  • The results indicated significantly increased glucose metabolism in finger and toe muscles, as well as asymmetric activity in thigh muscles, highlighting the potential of PET-CT for enhancing training methods in pitching and other throwing sports.
View Article and Find Full Text PDF

Objective: Colchicine has been used as an anti-inflammatory agent and may be cardioprotective after acute myocardial infarction (AMI). We investigated how colchicine administration after AMI affects the myocardial inflammatory response using C-methionine and subsequent ventricular remodeling using single-photon emission computed tomography (SPECT) in a rat model of AMI.

Methods: The left coronary artery (LCA) was occluded for 30 min followed by reperfusion.

View Article and Find Full Text PDF

I-meta-iodobenzylguanidine (I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy I-mIBG scintigraphy may detect more lesions compared with diagnostic I-mIBG scintigraphy. However, no studies have yet revealed the detection rate of hidden mIBG-avid lesions on post-therapy I-mIBG whole-body scan (WBS) and SPECT images in neuroblastoma children without mIBG-avid lesions as demonstrated by diagnostic I-mIBG scintigraphy.

View Article and Find Full Text PDF

Objective: Children with relapsed neuroblastoma have a poor prognosis despite modern multimodality therapy. Novel and more effective therapeutic strategies are required for relapsed neuroblastoma. We retrospectively examined the utility of consolidation therapy with high-dose I-meta-iodo-benzyl-guanidine (I-mIBG) in relapsed neuroblastoma or ganglioneuroblastoma patients with complete response (CR) to induction therapy as demonstrated by diagnostic I-mIBG scintigraphy.

View Article and Find Full Text PDF

Targeted radionuclide therapy with high-dose radioisotopes should be performed in isolation rooms. Patients can be released only after radioactivity remaining in their bodies becomes less than the limits determined by the release criteria in order to secure public protection. Patients are asked to stay in isolation rooms for a few days.

View Article and Find Full Text PDF